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
Prostate cancer typically develops later in life. Hence, identi‑
fying the botanical compounds that can prevent or delay disease 
progression may have a positive effect on the quality of life and 
reduce the healthcare costs of the aging population.[1] Supporting 
the statement, it could be accepted that the burden of increasing 
morbidity and mortality due to prostate cancer imposes a need for 
new, effective measures of prevention in daily life. Chemopreven‑
tion, a prophylactic approach that uses nontoxic natural or synthetic 
compounds to reverse, inhibit, or prevent cancer by targeting spe‑
cific steps in the carcinogenic pathway, is gaining traction among 
healthcare practitioners.[2] The World Health Organization (WHO) 
estimates that 80% of the population of developing countries relies 
on traditional medicine for their primary care needs. The emergence 
of resistance to cancer chemotherapy has forced researchers to 
turn to natural products of plant and marine origin.[3] Additionally, 
treatments for advanced disease are limited to hormone ablation 
techniques and palliative care. Thus, new methods of treatment 
and prevention are necessary for inhibiting disease progression to 
a hormone refractory state. One of the approaches to control pros‑
tate cancer is prevention through diet, which inhibits one or more 
neoplastic events and reduces the cancer risk.
For centuries, Ayurveda has recommended the use of bitter 
melon (Momordica charantia) as a functional food to prevent and 
treat human health related issues.[4] A study conducted by Ru et al. 
demonstrated that prostate cancer cells treated with bitter melon 
extract (BME) delayed the progression to high‑grade prostatic 
intraepithelial neoplasia in transgenic adenocarcinoma of mouse 
prostate (TRAMP) mice by 31%. Prostate tissue from BME‑fed mice 
displayed approximately 51% reduction of proliferating cell nuclear 
antigen expression. Together, results suggest that oral administration 
of BME inhibits prostate cancer progression in TRAMP mice by 
Dietary Botanicals for Chemoprevention of Prostate 
Cancer
Prasan Bhandari
Department of Pharmacology, Sri Dharmasthala Manjunatheshwara College of Medical Sciences and Hospital, Sattur, Dharwad,  Karnataka, India.
interfering with cell cycle progression and proliferation.[5]
Pomegranate juice (PJ) components luteolin, ellagic acid, and 
punicic acid together inhibit growth of hormone‑dependent and hor‑
mone‑refractory prostate cancer cells and inhibit their migration and 
chemotaxis toward stromal cell‑derived factor 1α (SDF1α), a che‑
mokine that is important in prostate cancer metastasis to the bone. 
Furthermore, they increase several well‑known tumor‑suppression 
microRNAs (miRNAs), decrease several oncogenic miRNAs, and 
inhibit the chemokine receptor type 4 (CXCR4)/SDF1α chemotaxis 
axis.[6] PJ has been associated with prostate‑specific antigen (PSA) 
doubling time (PSADT) elongation in men with prostate cancer in 
a phase II trial.[7] Additionally, Bhandari has reviewed the beneficial 
role of pomegranate in other disorders including prostate cancer.[8]
Gugulipid (GL), an extract of Indian Ayurvedic medicinal 
plant Commiphora mukul, has been used to treat a variety of ail‑
ments. Treatment with GL significantly inhibited the viability of 
human prostate cancer cell line LNCaP (androgen‑dependent) 
and its androgen‑independent variant. The GL‑induced growth 
inhibition correlated with apoptosis induction and cleavage of 
poly (ADP‑ribose) polymerase. The GL‑induced apoptosis was as‑
sociated with reactive oxygen species (ROS) production and c‑Jun 
NH (2)‑terminal kinase (JNK) activation.[9] The z‑guggulsterone 
treatment inhibited capillary‑like tube formation (in vitro neovascu‑
larization) by human umbilical vein endothelial cells (HUVEC) and 
migration by HUVEC and DU145 human prostate cancer cells in a 
concentration‑ and time‑dependent manner. These results provide 
compelling rationale for further preclinical and clinical investiga‑
tion of z‑guggulsterone for its efficacy against prostate cancer.[10]
S‑allylcysteine (SAC), a potent compound derived from garlic, 
suppressed the proliferation of PC‑3 cells and led to cell cycle arrest 
at the G0/G1 phases, as well as induced cell apoptosis, which was 
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accompanied by the decreased expression of Bcl‑2 and increased 
expression of Bax and caspase 8. This demonstrates the chemopre‑
ventive activity of SAC in vitro, and that SAC may be a promising 
candidate for prostate cancer treatment.[11] Diallyl disulfide (DADS) 
is another major component of an oil‑soluble allyl sulfide garlic (Al-
lium sativum) derivative. Inhibitory effects of DADS on prostate 
carcinoma LNCaP cells motility and invasiveness were found to be 
associated with increased tightness of the tight junctions (TJ), which 
was demonstrated by an increase in transepithelial electrical resis‑
tance (TER).[12] Additionally, results of the study conducted by Singh 
et al. indicate that oral administration of diallyl trisulfide (DATS) 
prevents development of poorly differentiated carcinoma and mul‑
tiplicity of pulmonary metastatic lesions in TRAMP mice without 
causing weight loss or affecting T‑antigen expression.[13]
Ginger (生薑 Shēng Jiāng; Zingiber officinale) is an excellent 
source of several bioactive phenolics, including non‑volatile pungent 
compounds such as gingerols, paradols, shogaols, and gingerones. 
Ginger has been known to display anti‑inflammatory, antioxidant, 
and antiproliferative activities, indicating its promising role as a 
chemopreventive agent. Whole ginger extract (GE) exerts signifi‑
cant growth‑inhibitory and death‑inductory effects in a spectrum of 
prostate cancer cells. GE perturbed cell cycle progression, impaired 
reproductive capacity, modulated cell cycle and apoptosis regulatory 
molecules, and induced a caspase‑driven, mitochondrially medi‑
ated apoptosis in human prostate cancer cells. Remarkably, daily 
oral feeding of 100 mg/kg body weight of GE inhibited growth 
and progression of PC‑3 xenografts by approximately 56% in nude 
mice, as shown by measurements of tumor volume. Thus, bioactive 
compounds from ginger show protective effects in both in vivo and 
in vitro prostate cancer models by modulation of proteins involved 
in apoptosis pathway.[14]
An analog of mahanine (alkaloid from Murraya koenigii, curry 
leaf) potently inhibited human prostate cancer cell proliferation 
in vitro, and dosing at 10 mg/kg reduced human xenograft tumor 
volume by about 40%.[15]
Furthermore, curcumin and silibinin too have been demon‑
strated to possess prostate cancer chemopreventive potential.[16,17]
Thus, cancer chemoprevention by phytochemicals could be 
one of the most reasonable methods for cancer control. Phyto‑
chemicals obtained from vegetables, fruits, spices, teas, herbs, 
and medicinal plants have been established to suppress experi‑
mental carcinogenesis in several organs, including prostate, in 
pre‑clinical models. Current studies have shown that mechanisms 
fundamental to chemopreventive potential might be a blend of 
antioxidant, anti‑inflammatory, immune‑enhancing, and hormone 
modulation effects. Moreover, alteration of drug metabolizing 
enzymes and effects on cell cycle and cell differentiation too are 
responsible. Stimulation of apoptosis, suppression of proliferation 
and angiogenesis also play a role in the initiation and secondary 
modification stages of neoplastic development. Particular features 
of prostate cancer, such as high prevalence and long latency period, 
offer sufficient prospects for chemopreventive agents to work 
at different stages of disease development. Finally, appropriate 
populations with applicable risk factors, including the presence of 
pre‑malignant lesions and genetic predispositions, need to be well 
characterized for future chemopreventive interventions.
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